Orbit Health Announced Additional 1 Million Funding From MTE, Closing Their Seed Round At 4 Million
Orbit Health, a Germany-based digital health startup, announced a €1 million investment from MedTech Entrepreneurs (MTE) to accelerate growth. After winning EIT Health’s Wild Card Challenge last year, Orbit further gained support from the BioInnovation Institute Foundation (BII) and industry advisors. With MTE’s latest investment, Orbit achieved €4 million in total funding to accelerate the venture’s development towards its goal to personalize care for Parkinson’s Disease and other chronic diseases through breakthrough digital health innovation.
Recommended AI News : Predictions Series 2022: Interview with Param Kahlon, Chief Product Officer at UiPath
Over 10 million people are living with Parkinson’s , yet each and every one of them experience different symptoms and respond to treatment differently. Orbit Health’s flagship solution ‘Neptune’ helps maximize symptom control for Parkinson’s patients. It harnesses the power of AI and utilizes only a smartwatch to enable personalized treatment, which is pressingly needed in ongoing Parkinson’s care.
“The future of healthcare is digital, especially in the rapidly growing chronic disease space. This is why MTE focuses on investing in promising MedTech and digital health startups and setting them up for success with our tremendous industry expertise and extensive network,” said Dominik Moll, Managing Partner of MTE. “We are excited to invest in Orbit. With their strong team, a clear focus, and excellent product-market fit, Orbit not only strengthens our portfolio, but also enhances our capacity to support high-potential HealthTech startups with their mission to transform healthcare.”
Biggest Ads of 2021: Can You Guess The 2021’S Most Emotionally Engaging Holiday Ads In The APAC Region?
To further deliver comprehensive patient insights and address the increasing threat of multiple chronic diseases, Orbit is enriching its solution by bringing together hundreds of relevant health and wellness data points including insights from common monitoring solutions such as blood pressure monitoring systems and glucose meters from siloed environments and integrating them with medical-grade, clinically validated digital health tools. The aim is to streamline the adoption and orchestration of novel digital health solutions and integrate them into the routine clinical workflows to achieve holistic patient care and real impact.
“We are excited to further strengthen Orbit with MTE’s support and be part of their vibrant ecosystem. ‘Neptune’ is a great example of how chronic diseases can be managed and in the future. It not only offers healthcare professionals the necessary insights to effectively personalize treatments and deliver timely interventions, but it also empowers patients to take better control of their conditions and to live life confidently,” said Patty Lee, CEO & Co-founder of Orbit Health. “We see remote personalized care powered by digital health and biomarker solutions as a way forward for chronic care because every patient is different, and a 24/7 condition deserves a 24/7 solution.”
“At least one in three adults has more than one chronic disease. Physicians are currently relying on only a snapshot of information to make treatment decisions. This makes the personalization of long-term care a huge challenge,” said Werner Boeing, former CIO of Roche Diagnostics and currently CEO & Co-founder of Evisory and Orbit Health advisor. “Digital biomarker solutions like Orbit’s Neptune can be the new pillar of diagnostics to address chronic disease burden and the ever-changing healthcare demand. I am extremely happy to see the progress Orbit has made thus far and look forward to continue to support them in their exciting journey ahead.”
Recommended AI News: FinClusive and Velo Labs Announce Partnership to Streamline Cross-Border Payments with Financial Crimes Compliance
[To share your insights with us, please write to sghosh@martechseries.com]
Comments are closed.